Skip to Content

Fanapt Approval History

  • FDA approved: Yes (First approved May 6th, 2009)
  • Brand name: Fanapt
  • Generic name: iloperidone
  • Dosage form: Tablets
  • Company: Vanda Pharmaceuticals Inc.
  • Treatment for: Schizophrenia

Fanapt (iloperidone) is a 5HT2/D2 antagonist (atypical) antipsychotic for the treatment of schizophrenia.

Development History and FDA Approval Process for Fanapt

DateArticle
May  7, 2009Approval FDA Approves Fanapt to Treat Schizophrenia
Nov 20, 2008FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
Jul 28, 2008Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
Nov 27, 2007Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
Sep 27, 2007Vanda Pharmaceuticals Submits Iloperidone New Drug Application

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide